Titan America SA Common Shares (TTAM)

16.31
+0.46 (2.90%)
NYSE· Last Trade: May 14th, 5:58 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Titan America (TTAM) Q1 2026 Earnings Transcriptfool.com
Titan America (TTAM) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Titan America SA (NYSE:TTAM) Q1 2026 Results Mixed as Earnings Miss Overshadow Revenue Growth and Reaffirmed Guidancechartmill.com
Via Chartmill · May 5, 2026
Titan America (TTAM) Q4 2025 Earnings Transcriptfool.com
Titan America (TTAM) Q4 2025 Earnings Transcript
Via The Motley Fool · March 18, 2026
TITAN AMERICA SA (NYSE:TTAM) Reports Mixed Q4 2025 Results, Stock Falls on Revenue and EPS Misschartmill.com
Via Chartmill · March 17, 2026
Earnings Scheduled For November 5, 2025benzinga.com
Via Benzinga · November 5, 2025
Earnings Scheduled For July 29, 2025benzinga.com
Via Benzinga · July 29, 2025
Earnings Scheduled For May 5, 2025benzinga.com
Via Benzinga · May 5, 2025
A Glimpse of Titan America's Earnings Potentialbenzinga.com
Via Benzinga · May 2, 2025
Earnings Scheduled For March 26, 2025benzinga.com
Via Benzinga · March 26, 2025
This Tevogen Bio Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · March 4, 2025
Sionna Therapeutics, Titan America Made Public Debuttalkmarkets.com
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025